Presentation is loading. Please wait.

Presentation is loading. Please wait.

Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate  Pythia T Nieuwkerk,

Similar presentations


Presentation on theme: "Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate  Pythia T Nieuwkerk,"— Presentation transcript:

1 Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate  Pythia T Nieuwkerk, Petra J Hajenius, M.D., Fulco Van der Veen, M.D., Ph.D., Willem M Ankum, M.D., Ph.D., Wouter Wijker, Ph.D., Patrick M.M Bossuyt, Ph.D.  Fertility and Sterility  Volume 70, Issue 3, Pages (September 1998) DOI: /S (98)

2 FIGURE 1 Patient preferences for systemic methotrexate therapy relative to laparoscopic salpingostomy. • = patients treated with systemic methotrexate; ∗ = patients treated by salpingostomy; □ = control patients. Vertical dotted line at 80% = tubal patency rate after salpingostomy. Fertility and Sterility  , DOI: ( /S (98) )


Download ppt "Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate  Pythia T Nieuwkerk,"

Similar presentations


Ads by Google